...
首页> 外文期刊>Molecular and Cellular Endocrinology >Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells
【24h】

Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells

机译:HTERT沉默的沉默块增长和迁移甲状腺癌细胞

获取原文
获取原文并翻译 | 示例

摘要

Mutations in the hTERT promoter responsible for constitutive telomerase activity are the most frequent genetic alteration detected in anaplastic thyroid cancer (ATC), and proposed as diagnostic and prognostic biomarker in these tumours. In this study we analyzed hTERT expression in a series of human ATCs and investigated the effects of small-interfering RNA-mediated silencing of hTERT on viability and migration and invasive properties of three human ATC cell lines. Expression of hTERT mRNA resulted increased in 8/10 ATCs compared to normal thyroid tissues. Silencing of hTERT in CAL-62, 8505C and SW1736 cells did not modify telomere length but determined a significant decrease (about 50%) of cell proliferation in all cell lines and a great reduction (about 50%) of migration and invasion capacity. These finding demonstrate that hTERT may be considered as a molecular target for ATC treatment. (C) 2017 Elsevier B.V. All rights reserved.
机译:负责组成型端粒酶活性的HTERT启动子中的突变是在激增的甲状腺癌(ATC)中检测到最常见的遗传改变,并且在这些肿瘤中提出诊断和预后生物标志物。 在这项研究中,我们分析了一系列人ATC中的HTERT表达,并研究了小干扰RNA介导的HTERT对三种人ATC细胞系的活力和迁移和侵入性质的影响。 与正常的甲状腺组织相比,8/10 ATC导致HTERT mRNA的表达增加。 Cal-62,8505C和SW1736细胞中HTERT的沉默没有修饰端粒长度,但确定所有细胞系中细胞增殖的显着降低(约50%),迁移和侵袭能力的大量减少(约50%)。 这些发现表明,HTERT可以被认为是ATC治疗的分子靶标。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号